Baudax Bio Inc reports results for the quarter ended in December - Earnings Summary

Baudax Bio

16/03/2022 13:41

* Baudax Bio Inc  BXRX.OQ  reported quarterly adjusted
earnings of
$10.03​​ per share for the quarter ended in December. The mean
expectation of two analysts for the quarter was for earnings of
$1.48 per share.
    * Revenue rose 426.3% to $400.00 thousand from a year ago; 
analysts expected $625.00 thousand. 
    * Baudax Bio Inc's reported EPS for the quarter was $10.03​.
    * The mean earnings estimate of analysts had risen by
about 128.1%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Baudax Bio Inc shares had fallen by 78.9% this quarter.
    * The company reported quarterly net income of $27.01
million.
    * Wall Street's median 12-month price target for Baudax Bio
Inc is
$44.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated March 16 at 01:41 p.m.  ​All
figures in US dollars unless otherwise stated